mDataType,dataset_name,drug_name,sens_stat,estimate,pvalue,drug_id,tissue mRNA,CTRPv2,EX-527,AAC,0.244148129258348,1.43307079945129e-10,293,pan-cancer mRNA,CTRPv2,BRD-K16147474,AAC,0.239201048830184,7.63459972619418e-10,115,pan-cancer mRNA,CTRPv2,BRD-K02251932,AAC,0.131499475530624,0.000590853350272014,102,pan-cancer mRNA,CTRPv2,Bleomycin,AAC,0.118195086813513,0.00155776507267583,84,pan-cancer mRNA,CTRPv2,CID-5951923,AAC,-0.102879795936694,0.0068234867974236,230,pan-cancer mRNA,CTRPv2,BRD-K51490254,AAC,0.100425052978282,0.00742347862402556,146,pan-cancer mRNA,CTRPv2,ML311,AAC,0.0846259162213588,0.00857965409216002,458,pan-cancer mRNA,CTRPv2,1S,3R-RSL-3,AAC,-0.0863838763028902,0.00873393443873401,4,pan-cancer mRNA,CTRPv2,BRD-K41334119,AAC,-0.437037279596059,0.00953883789121124,137,pan-cancer mRNA,CTRPv2,NSC 74859,AAC,0.0958468092297582,0.0122279015627551,495,pan-cancer mRNA,CTRPv2,N9-isopropylolomoucine,AAC,-0.0892677822679067,0.012598262079757,472,pan-cancer mRNA,CTRPv2,ML162,AAC,-0.0815567996508934,0.0153260215733632,453,pan-cancer mRNA,CTRPv2,BRD-K24690302,AAC,-0.0871311242307764,0.0162544435530304,119,pan-cancer mRNA,CTRPv2,BRD-K14844214,AAC,0.0921122337779357,0.0166257582745387,113,pan-cancer mRNA,CTRPv2,JQ-1:vorinostat (2:1 mol/mol),AAC,-0.0777958508978805,0.0187244641568142,387,pan-cancer mRNA,CTRPv2,AM-580,AAC,-0.0864987325821189,0.0192110853794183,30,pan-cancer mRNA,CTRPv2,ML203,AAC,-0.0875587814895971,0.0194872928087375,454,pan-cancer mRNA,CTRPv2,Cytarabine,AAC,0.0654808173145741,0.0201041473240743,257,pan-cancer mRNA,CTRPv2,BRD-K84807411,AAC,-0.371407972518988,0.0208563336109886,164,pan-cancer mRNA,CTRPv2,BRD-K07442505,AAC,-0.082515659575735,0.0245920106144641,107,pan-cancer mRNA,CTRPv2,CAL-101,AAC,0.0806790764439342,0.0260148045434667,194,pan-cancer mRNA,CTRPv2,Bosutinib,AAC,0.0763034296795875,0.0269344047949847,93,pan-cancer mRNA,CTRPv2,indisulam,AAC,0.0703318852643753,0.0278291171417188,363,pan-cancer mRNA,CTRPv2,SCH-79797,AAC,0.0752956764278,0.0316878050405583,617,pan-cancer mRNA,CTRPv2,cimetidine,AAC,-0.180582838464159,0.0327113018569393,236,pan-cancer mRNA,CTRPv2,ML006,AAC,0.0761950270665941,0.0401653124050499,449,pan-cancer mRNA,CTRPv2,staurosporine,AAC,-0.149691892280559,0.0437212698878617,658,pan-cancer mRNA,CTRPv2,tanespimycin:gemcitabine (1:1 mol/mol),AAC,0.0652849826341714,0.0442022597515724,676,pan-cancer mRNA,CTRPv2,linifanib,AAC,-0.070817265398116,0.0444326647034725,424,pan-cancer mRNA,CTRPv2,isoevodiamine,AAC,0.0643296541464421,0.0470869153923333,368,pan-cancer mRNA,CTRPv2,BRD-K03536150,AAC,-0.0732280168420225,0.048931861397524,104,pan-cancer mRNA,CTRPv2,tipifarnib,AAC,0.0608862829103227,0.050645806866525,690,pan-cancer mRNA,CTRPv2,YK 4-279,AAC,0.0612306625082999,0.0536029387135135,750,pan-cancer mRNA,CTRPv2,selumetinib:piperlongumine (8:1 mol/mol),AAC,-0.0669664971225951,0.0550406200140949,624,pan-cancer mRNA,CTRPv2,ML258,AAC,0.071978662289334,0.0552233077196455,457,pan-cancer mRNA,CTRPv2,MLN4924,AAC,0.0648707496074427,0.0566493789633538,464,pan-cancer mRNA,CTRPv2,Carboplatin,AAC,-0.0680363889477008,0.0572203586508755,197,pan-cancer mRNA,CTRPv2,JQ-1:UNC0638 (2:1 mol/mol),AAC,-0.0650573109295701,0.0596675734391347,386,pan-cancer mRNA,CTRPv2,BRD-K27986637,AAC,-0.303440890741555,0.0650146675370742,124,pan-cancer mRNA,CTRPv2,necrostatin-7,AAC,-0.0675790740451538,0.0661561751374394,483,pan-cancer mRNA,CTRPv2,NSC23766,AAC,0.0630912163547561,0.0682360880897588,499,pan-cancer mRNA,CTRPv2,NVP-231,AAC,0.0586073167923447,0.0698583475305256,509,pan-cancer mRNA,CTRPv2,BRD-K48334597,AAC,-0.274928630491873,0.0715577060406559,142,pan-cancer mRNA,CTRPv2,BRD-K50799972,AAC,0.0659971783209271,0.0776222911308221,145,pan-cancer mRNA,CTRPv2,BRD-K30019337,AAC,-0.274698570655672,0.0781226163749271,128,pan-cancer mRNA,CTRPv2,AZD1480,AAC,0.0931198076770184,0.0804881959975269,54,pan-cancer mRNA,CTRPv2,isoliquiritigenin,AAC,-0.265599949829555,0.084533474004685,369,pan-cancer mRNA,CTRPv2,Compound 23 citrate,AAC,0.0580216829894962,0.0857445408159016,243,pan-cancer mRNA,CTRPv2,ruxolitinib,AAC,0.0589857796987908,0.0869133443899086,602,pan-cancer mRNA,CTRPv2,BRD-K04800985,AAC,-0.0638617291586373,0.0905904735219771,106,pan-cancer mRNA,CTRPv2,MGCD-265,AAC,0.0580932744911596,0.0908798588971183,441,pan-cancer mRNA,CTRPv2,BRD-K27188169,AAC,0.0919647484916563,0.0928262218959066,121,pan-cancer mRNA,CTRPv2,BRD-K30748066,AAC,-0.203200464060337,0.0928625467086983,129,pan-cancer mRNA,CTRPv2,JQ-1:navitoclax (2:1 mol/mol),AAC,-0.0568115782805657,0.0932708312999378,385,pan-cancer mRNA,CTRPv2,BRD-K94991378,AAC,-0.0648420685208985,0.0933114418908618,170,pan-cancer mRNA,CTRPv2,tivozanib,AAC,0.0617930648820715,0.093328388763293,693,pan-cancer mRNA,CTRPv2,tigecycline,AAC,0.080346813501303,0.0951010432781938,689,pan-cancer mRNA,CTRPv2,HLI 373,AAC,0.0589609017545917,0.0972494915006943,351,pan-cancer mRNA,CTRPv2,JNJ-26854165,AAC,0.0545976399116626,0.1104829615791,379,pan-cancer mRNA,CTRPv2,fulvestrant,AAC,-0.127812488654512,0.111013232250181,308,pan-cancer mRNA,CTRPv2,BRD-K13185470,AAC,0.139695108030434,0.113930770285639,111,pan-cancer mRNA,CTRPv2,ML210,AAC,-0.0514052027800236,0.114544732653431,455,pan-cancer mRNA,CTRPv2,vorapaxar,AAC,-0.0587419712617713,0.120344441394862,724,pan-cancer mRNA,CTRPv2,QW-BI-011,AAC,0.106143132772651,0.123467466785795,588,pan-cancer mRNA,CTRPv2,tamatinib,AAC,-0.0567653727004855,0.124145358526277,672,pan-cancer mRNA,CTRPv2,ciclosporin,AAC,-0.0572117351369673,0.127278737566475,229,pan-cancer mRNA,CTRPv2,5-FU,AAC,0.051306893613622,0.129131164120787,7,pan-cancer mRNA,CTRPv2,SKI-II,AAC,-0.0555769541986497,0.131115477776089,644,pan-cancer mRNA,CTRPv2,cyanoquinoline 11,AAC,0.080688931719326,0.132319887106327,254,pan-cancer mRNA,CTRPv2,crizotinib:PLX-4032 (2:1 mol/mol),AAC,0.0516034851046867,0.13252140094914,249,pan-cancer mRNA,CTRPv2,erastin,AAC,-0.0520682797624738,0.13512123541971,284,pan-cancer mRNA,CTRPv2,Methotrexate,AAC,0.0546526318271131,0.137255803295875,438,pan-cancer mRNA,CTRPv2,KU-60019,AAC,-0.0515730416948091,0.137752911474605,410,pan-cancer mRNA,CTRPv2,selumetinib:JQ-1 (4:1 mol/mol),AAC,0.0495413694220235,0.148590959814055,621,pan-cancer mRNA,CTRPv2,JQ-1,AAC,-0.0448520311021647,0.150737795397953,382,pan-cancer mRNA,CTRPv2,GSK4112,AAC,-0.0527019444519467,0.151325655827088,336,pan-cancer mRNA,CTRPv2,ISOX:bortezomib (250:1 mol/mol),AAC,0.050349608709715,0.151384998722871,372,pan-cancer mRNA,CTRPv2,BRD-K44224150,AAC,-0.109785095004636,0.151963929890214,140,pan-cancer mRNA,CTRPv2,HC-067047,AAC,-0.0537466094023531,0.153944627263785,347,pan-cancer mRNA,CTRPv2,etoposide,AAC,0.0421224354467612,0.1540076862736,290,pan-cancer mRNA,CTRPv2,BRD-K70511574,AAC,0.0460385338584577,0.154369175322707,157,pan-cancer mRNA,CTRPv2,WZ8040,AAC,-0.0555457475544576,0.156598014770496,738,pan-cancer mRNA,CTRPv2,JQ-1:MK-0752 (1:1 mol/mol),AAC,-0.047822051673361,0.158697531009833,384,pan-cancer mRNA,CTRPv2,PI-103,AAC,-0.0488653309507511,0.158720815317415,558,pan-cancer mRNA,CTRPv2,palmostatin B,AAC,-0.062686267414371,0.159448918296222,527,pan-cancer mRNA,CTRPv2,Cerulenin,AAC,-0.0456870572155933,0.160744082102601,213,pan-cancer mRNA,CTRPv2,doxorubicin:navitoclax (2:1 mol/mol),AAC,0.045631354891275,0.160994681131912,274,pan-cancer mRNA,CTRPv2,selumetinib:tretinoin (2:1 mol/mol),AAC,-0.0489967038880599,0.164626576800559,626,pan-cancer mRNA,CTRPv2,NSC632839,AAC,0.046645677985683,0.16641840558779,502,pan-cancer mRNA,CTRPv2,VER-155008,AAC,0.0492959461662526,0.167513982763188,719,pan-cancer mRNA,CTRPv2,L-685458,AAC,-0.0508429489575982,0.1682583460407,413,pan-cancer mRNA,CTRPv2,austocystin d,AAC,-0.050357263764056,0.169537958907413,43,pan-cancer mRNA,CTRPv2,CAY10618,AAC,0.0474724596135336,0.171534012532025,203,pan-cancer mRNA,CTRPv2,PF-750,AAC,-0.0517791792710561,0.172492320067994,552,pan-cancer mRNA,CTRPv2,dacarbazine,AAC,0.0431774011536321,0.173081892684506,260,pan-cancer mRNA,CTRPv2,BRD-K63431240,AAC,0.0477555838282455,0.17506021697119,153,pan-cancer mRNA,CTRPv2,PRL-3 Inhibitor I,AAC,0.0520099042030735,0.17624574725953,572,pan-cancer mRNA,CTRPv2,BRD4132,AAC,-0.0509261855580474,0.177395905340714,179,pan-cancer mRNA,CTRPv2,TG-101348,AAC,0.0453120772778437,0.177922292223902,683,pan-cancer mRNA,CTRPv2,PF-543,AAC,0.0500399631442609,0.178916799935765,549,pan-cancer mRNA,CTRPv2,Doxorubicin,AAC,0.0396645376718054,0.182272670109665,273,pan-cancer mRNA,CTRPv2,nakiterpiosin,AAC,0.0440862616608599,0.182931817944047,473,pan-cancer mRNA,CTRPv2,carboplatin:UNC0638 (2:1 mol/mol),AAC,-0.0496416952097185,0.183768131868636,199,pan-cancer mRNA,CTRPv2,ML320,AAC,-0.0468422268910229,0.186002026088359,460,pan-cancer mRNA,CTRPv2,PDMP,AAC,0.0494413636823108,0.186137178468361,540,pan-cancer mRNA,CTRPv2,BRD-K49290616,AAC,-0.236933780541778,0.187567169095395,144,pan-cancer mRNA,CTRPv2,Gemcitabine,AAC,0.0434740899116626,0.187661541738613,316,pan-cancer mRNA,CTRPv2,lenvatinib,AAC,0.047873709362744,0.188340294647871,420,pan-cancer mRNA,CTRPv2,SR-II-138A,AAC,0.0409540595712756,0.19121183802518,654,pan-cancer mRNA,CTRPv2,IC-87114,AAC,0.0484073008197485,0.191402435130955,357,pan-cancer mRNA,CTRPv2,Crizotinib,AAC,0.0420559407630562,0.192417557519445,248,pan-cancer mRNA,CTRPv2,CHIR-99021,AAC,0.0431160185720531,0.196857384764597,223,pan-cancer mRNA,CTRPv2,BRD-A02303741:navitoclax (2:1 mol/mol),AAC,0.0461831271730705,0.197351218200925,96,pan-cancer mRNA,CTRPv2,BRD-K71935468,AAC,-0.0483903862021685,0.200735577432405,159,pan-cancer mRNA,CTRPv2,fingolimod,AAC,0.0449949662245191,0.205513364368626,297,pan-cancer mRNA,CTRPv2,BIBR-1532,AAC,-0.0463589552067646,0.205847116098689,75,pan-cancer mRNA,CTRPv2,BRD-K55473186,AAC,0.0587762891307712,0.206185123595628,150,pan-cancer mRNA,CTRPv2,AZD8055,AAC,-0.0440253377396513,0.209803553244815,59,pan-cancer mRNA,CTRPv2,temsirolimus,AAC,0.0600376468783641,0.210300375744291,680,pan-cancer mRNA,CTRPv2,thalidomide,AAC,0.0671262684655354,0.213559098107627,685,pan-cancer mRNA,CTRPv2,BRD-K66532283,AAC,-0.0413010174186864,0.214153272479412,156,pan-cancer mRNA,CTRPv2,narciclasine,AAC,0.0409446992469231,0.214164991652004,474,pan-cancer mRNA,CTRPv2,BRD-K33199242,AAC,-0.0465141602181123,0.21422182228506,130,pan-cancer mRNA,CTRPv2,vincristine,AAC,0.037425067879285,0.216594702211054,721,pan-cancer mRNA,CTRPv2,NVP-ADW742,AAC,0.0431175440671176,0.219517787737593,510,pan-cancer mRNA,CTRPv2,BMS-195614,AAC,-0.0467302871716594,0.220891060875595,85,pan-cancer mRNA,CTRPv2,BRD-K66453893,AAC,0.0380527843967223,0.223564726247343,155,pan-cancer mRNA,CTRPv2,Parthenolide,AAC,-0.0459115339607751,0.224464675273533,531,pan-cancer mRNA,CTRPv2,Platin,AAC,-0.0449995592926994,0.224585168086639,566,pan-cancer mRNA,CTRPv2,CR-1-31B,AAC,0.0391926405831477,0.224843873875636,247,pan-cancer mRNA,CTRPv2,apicidin,AAC,-0.0375241330983103,0.224900527882905,33,pan-cancer mRNA,CTRPv2,BRD-K78574327,AAC,-0.20644135457578,0.229372449821418,161,pan-cancer mRNA,CTRPv2,Oxaliplatin,AAC,0.0387530098066991,0.236150242779297,523,pan-cancer mRNA,CTRPv2,AZD-2281,AAC,0.0405560818209714,0.242465389126169,51,pan-cancer mRNA,CTRPv2,BRD-K55116708,AAC,0.0423297512489428,0.244068675702469,149,pan-cancer mRNA,CTRPv2,selumetinib:PLX-4032 (8:1 mol/mol),AAC,-0.040699816207591,0.245379161828848,625,pan-cancer mRNA,CTRPv2,BRD-K29086754,AAC,-0.0875803830428444,0.250046435144628,126,pan-cancer mRNA,CTRPv2,GSK1059615,AAC,-0.0518729575650222,0.250683455246667,326,pan-cancer mRNA,CTRPv2,BRD-K88742110,AAC,0.0411398220633215,0.253227520521725,167,pan-cancer mRNA,CTRPv2,purmorphamine,AAC,-0.0429649525135304,0.25451091232629,575,pan-cancer mRNA,CTRPv2,PRIMA-1-Met,AAC,0.0604001316023977,0.255074416644445,571,pan-cancer mRNA,CTRPv2,I-BET151,AAC,-0.0348831721560204,0.256206067696497,354,pan-cancer mRNA,CTRPv2,manumycin A,AAC,-0.0358063158153177,0.256978450699042,432,pan-cancer mRNA,CTRPv2,BIBW2992,AAC,-0.0409289010158723,0.25706929344119,76,pan-cancer mRNA,CTRPv2,LE-135,AAC,-0.0407016852471153,0.257682724461806,418,pan-cancer mRNA,CTRPv2,docetaxel:tanespimycin (2:1 mol/mol),AAC,0.0365128884109613,0.260085982917247,272,pan-cancer mRNA,CTRPv2,BRD-K41597374,AAC,0.0392768473340173,0.260190018887082,138,pan-cancer mRNA,CTRPv2,OSI-906,AAC,0.0393934727893925,0.263286662357611,519,pan-cancer mRNA,CTRPv2,elocalcitol,AAC,0.0383106965312668,0.263496633251589,279,pan-cancer mRNA,CTRPv2,BRD-K29313308,AAC,-0.0409493158567506,0.263658876281372,127,pan-cancer mRNA,CTRPv2,Axitinib,AAC,0.037614700086623,0.266366573196456,47,pan-cancer mRNA,CTRPv2,prima-1,AAC,-0.0346688392423297,0.267892835096058,570,pan-cancer mRNA,CTRPv2,AGK-2,AAC,0.0414441996082213,0.268834509794188,24,pan-cancer mRNA,CTRPv2,BIX-01294,AAC,0.0377824764498018,0.270516929620225,81,pan-cancer mRNA,CTRPv2,navitoclax:gemcitabine (1:1 mol/mol),AAC,0.0371721293068884,0.271940469712592,476,pan-cancer mRNA,CTRPv2,BRD-K16130065,AAC,0.0807077088320824,0.275898529508789,114,pan-cancer mRNA,CTRPv2,selumetinib:vorinostat (8:1 mol/mol),AAC,-0.0394810250754596,0.275940448202647,628,pan-cancer mRNA,CTRPv2,selumetinib:UNC0638 (4:1 mol/mol),AAC,-0.0378254002230604,0.278057627413829,627,pan-cancer mRNA,CTRPv2,FSC231,AAC,-0.0779551007782825,0.278847833588446,305,pan-cancer mRNA,CTRPv2,CAY10594,AAC,0.0405369330269676,0.281801959306326,201,pan-cancer mRNA,CTRPv2,gossypol,AAC,-0.0394659112865759,0.283072775176689,321,pan-cancer mRNA,CTRPv2,CHEMBL1222381,AAC,-0.0354816257254278,0.283132725271135,221,pan-cancer mRNA,CTRPv2,piperlongumine:MST-312 (1:1 mol/mol),AAC,-0.0376892326672853,0.283955827330471,563,pan-cancer mRNA,CTRPv2,BRD-A02303741,AAC,0.0414636051997907,0.283996562795607,94,pan-cancer mRNA,CTRPv2,neratinib,AAC,-0.0377837301502889,0.284478147209394,488,pan-cancer mRNA,CTRPv2,alisertib:navitoclax (2:1 mol/mol),AAC,0.0372419419073923,0.287560939083903,28,pan-cancer mRNA,CTRPv2,Bexarotene,AAC,-0.0382396108467735,0.288013652033355,72,pan-cancer mRNA,CTRPv2,GSK461364,AAC,0.0334286701286743,0.289137006435224,338,pan-cancer mRNA,CTRPv2,AA-COCF3,AAC,0.0374920167583964,0.289458756078854,13,pan-cancer mRNA,CTRPv2,BRD8958,AAC,-0.0408906046373093,0.291282495574332,182,pan-cancer mRNA,CTRPv2,QS11,AAC,-0.177972459486402,0.292522426962788,586,pan-cancer mRNA,CTRPv2,Teniposide,AAC,0.043377755003527,0.294063793928629,681,pan-cancer mRNA,CTRPv2,YL54,AAC,-0.0405229043849466,0.29723806132339,751,pan-cancer mRNA,CTRPv2,ELCPK,AAC,0.0544239380223547,0.30185884868612,277,pan-cancer mRNA,CTRPv2,tacedinaline,AAC,-0.0384625543510715,0.305658074173992,667,pan-cancer mRNA,CTRPv2,lapatinib,AAC,-0.0362759351703943,0.307864335352308,415,pan-cancer mRNA,CTRPv2,BRD9647,AAC,-0.0375088589648114,0.309425707576342,183,pan-cancer mRNA,CTRPv2,avicin D,AAC,0.0552256799842782,0.310040484823705,45,pan-cancer mRNA,CTRPv2,tretinoin:carboplatin (2:1 mol/mol),AAC,-0.0354726712645012,0.311441108827663,700,pan-cancer mRNA,CTRPv2,DBeQ,AAC,-0.0367760180223929,0.312102621834998,263,pan-cancer mRNA,CTRPv2,BRD-K02492147,AAC,-0.0410033818939269,0.312846503601952,103,pan-cancer mRNA,CTRPv2,BRD-K35604418,AAC,-0.0370990863627998,0.313867520116865,135,pan-cancer mRNA,CTRPv2,ifosfamide,AAC,0.0555841281754617,0.314570757915184,359,pan-cancer mRNA,CTRPv2,AT13387,AAC,0.0464319588742122,0.315876448781177,40,pan-cancer mRNA,CTRPv2,CIL56,AAC,-0.0460571701717827,0.316674168568503,234,pan-cancer mRNA,CTRPv2,BRD-K85133207,AAC,0.0367883423006805,0.318555878276217,165,pan-cancer mRNA,CTRPv2,PX-12,AAC,0.0280106556253315,0.32674336256763,577,pan-cancer mRNA,CTRPv2,alisertib,AAC,0.0306382820345258,0.32687586988776,27,pan-cancer mRNA,CTRPv2,MK 1775,AAC,0.0329503195946779,0.327843048578913,446,pan-cancer mRNA,CTRPv2,Rapamycin,AAC,-0.0332528423329851,0.329719265017617,591,pan-cancer mRNA,CTRPv2,erlotinib:PLX-4032 (2:1 mol/mol),AAC,-0.0365825283905744,0.329740601900585,288,pan-cancer mRNA,CTRPv2,ML239,AAC,0.0348102421566273,0.330607905866718,456,pan-cancer mRNA,CTRPv2,sitagliptin,AAC,-0.168745635885014,0.331022739221011,641,pan-cancer mRNA,CTRPv2,RO4929097,AAC,-0.0522564567637936,0.332467168592829,599,pan-cancer mRNA,CTRPv2,selumetinib:BRD-A02303741 (4:1 mol/mol),AAC,-0.0333833467901019,0.335856501118138,618,pan-cancer mRNA,CTRPv2,FQI-2,AAC,0.0307450347241154,0.337095590436399,303,pan-cancer mRNA,CTRPv2,BRD-K99584050,AAC,0.0507367755177863,0.337476135341286,175,pan-cancer mRNA,CTRPv2,BRD-K90370028,AAC,0.0520187465441657,0.346545808290267,168,pan-cancer mRNA,CTRPv2,BRD-K09344309,AAC,0.0722011257258241,0.350272007905377,108,pan-cancer mRNA,CTRPv2,ML083,AAC,-0.0362587200708424,0.350503432801371,452,pan-cancer mRNA,CTRPv2,istradefylline,AAC,0.0519694708184939,0.350815948695412,375,pan-cancer mRNA,CTRPv2,KX2-391,AAC,0.0296626194213207,0.355053768643055,412,pan-cancer mRNA,CTRPv2,BRD9876,AAC,-0.0346925659893453,0.358368397296194,184,pan-cancer mRNA,CTRPv2,GW-405833,AAC,-0.0313004598683431,0.358446646647837,344,pan-cancer mRNA,CTRPv2,BRD-K61166597,AAC,-0.0292894735996371,0.358694788259863,152,pan-cancer mRNA,CTRPv2,tosedostat,AAC,0.0331059859902288,0.359205428567868,698,pan-cancer mRNA,CTRPv2,VAF-347,AAC,0.0423277321598834,0.359404481264606,714,pan-cancer mRNA,CTRPv2,PHA-793887,AAC,0.0286642587125197,0.359725896085326,555,pan-cancer mRNA,CTRPv2,ZSTK474,AAC,0.0337799659571763,0.364385706036657,759,pan-cancer mRNA,CTRPv2,darinaparsin,AAC,0.0479419040628304,0.366404657848404,261,pan-cancer mRNA,CTRPv2,tivantinib,AAC,-0.0406309485001666,0.36783055321053,692,pan-cancer mRNA,CTRPv2,ML050,AAC,-0.0331016438615893,0.368797822526739,451,pan-cancer mRNA,CTRPv2,BRD-K92856060,AAC,0.0326191216505191,0.368884649314682,169,pan-cancer mRNA,CTRPv2,BRD-K27188169:navitoclax (2:1 mol/mol),AAC,-0.0470731924663972,0.369513390077299,122,pan-cancer mRNA,CTRPv2,SN-38,AAC,0.0332129730993831,0.370288103471205,647,pan-cancer mRNA,CTRPv2,pandacostat,AAC,0.0332375597600344,0.370426949851422,528,pan-cancer mRNA,CTRPv2,paclitaxel,AAC,0.0294552105871068,0.371443960688766,526,pan-cancer mRNA,CTRPv2,birinapant,AAC,-0.0334746563638928,0.372469893103938,80,pan-cancer mRNA,CTRPv2,tandutinib,AAC,-0.0314819723739592,0.381413638631071,674,pan-cancer mRNA,CTRPv2,BRD-K45681478,AAC,-0.0313089766411708,0.381535290121507,141,pan-cancer mRNA,CTRPv2,pluripotin,AAC,0.0302368833023485,0.388812999481606,567,pan-cancer mRNA,CTRPv2,Sildenafil,AAC,-0.0323458183475986,0.393420356319418,637,pan-cancer mRNA,CTRPv2,parbendazole,AAC,0.0262279268844189,0.395111309018978,530,pan-cancer mRNA,CTRPv2,itraconazole,AAC,-0.0320355013677768,0.395218320184487,376,pan-cancer mRNA,CTRPv2,necrostatin-1,AAC,0.0313371728223789,0.395523397612471,482,pan-cancer mRNA,CTRPv2,masitinib,AAC,0.0309297685395145,0.399118910531,434,pan-cancer mRNA,CTRPv2,pitstop2,AAC,-0.0380812981598713,0.402776977590973,564,pan-cancer mRNA,CTRPv2,lovastatin,AAC,-0.0304440763820282,0.406517333153167,427,pan-cancer mRNA,CTRPv2,Repligen 136,AAC,-0.0304680296514339,0.406520149518843,594,pan-cancer mRNA,CTRPv2,myriocin,AAC,0.0825171905503718,0.407285327247095,471,pan-cancer mRNA,CTRPv2,Ko-143,AAC,-0.0302012929537607,0.407728314391498,405,pan-cancer mRNA,CTRPv2,COL-3,AAC,0.0306739774202522,0.408940158554373,240,pan-cancer mRNA,CTRPv2,rigosertib,AAC,0.0272785711697543,0.409054393332765,596,pan-cancer mRNA,CTRPv2,serdemetan:SCH-529074 (1:1 mol/mol),AAC,0.0287036490552387,0.40914116338372,631,pan-cancer mRNA,CTRPv2,AZD6244,AAC,-0.0290916542929697,0.413342655198479,56,pan-cancer mRNA,CTRPv2,piperlongumine,AAC,0.0261485003043912,0.414676790677129,562,pan-cancer mRNA,CTRPv2,Topotecan,AAC,0.0256930630693783,0.417982888665344,697,pan-cancer mRNA,CTRPv2,dexamethasone,AAC,0.0262937997207397,0.426041898151531,267,pan-cancer mRNA,CTRPv2,tretinoin:navitoclax (4:1 mol/mol),AAC,-0.0277706688220578,0.426158347748986,701,pan-cancer mRNA,CTRPv2,BRD1835,AAC,-0.0297799809607155,0.427972071137915,178,pan-cancer mRNA,CTRPv2,JQ-1:carboplatin (1:1 mol/mol),AAC,-0.0254140825537526,0.429504959303268,383,pan-cancer mRNA,CTRPv2,compound 1B,AAC,-0.0300414806475711,0.431146231012586,242,pan-cancer mRNA,CTRPv2,RG-108,AAC,-0.0281504666833563,0.433358688130766,595,pan-cancer mRNA,CTRPv2,vorinostat:carboplatin (1:1 mol/mol),AAC,0.0264200580303272,0.435201960920438,726,pan-cancer mRNA,CTRPv2,Mitomycin-C,AAC,0.0258835459260549,0.435560035107491,445,pan-cancer mRNA,CTRPv2,Compound 7d-cis,AAC,-0.0286471317997611,0.436113923843794,244,pan-cancer mRNA,CTRPv2,MK-0752,AAC,-0.0296398216363843,0.438941291600229,447,pan-cancer mRNA,CTRPv2,YM-155,AAC,-0.0292275068474941,0.439446568346969,752,pan-cancer mRNA,CTRPv2,selumetinib:MK-2206 (8:1 mol/mol),AAC,-0.0268841673771579,0.443220034343466,622,pan-cancer mRNA,CTRPv2,BRD-K80183349,AAC,-0.0245905530855484,0.445531967946919,163,pan-cancer mRNA,CTRPv2,Panobinostat,AAC,-0.0254023581487477,0.44554720304629,529,pan-cancer mRNA,CTRPv2,GSK525762A,AAC,0.0224781981164926,0.449661364780317,339,pan-cancer mRNA,CTRPv2,MG-132,AAC,-0.0454137499995601,0.452882990791117,440,pan-cancer mRNA,CTRPv2,LRRK2-IN-1,AAC,-0.0273028086554593,0.456274191420632,428,pan-cancer mRNA,CTRPv2,valdecoxib,AAC,0.0265642290997001,0.457721836874336,715,pan-cancer mRNA,CTRPv2,fluvastatin,AAC,0.0272020556579171,0.458100864740222,299,pan-cancer mRNA,CTRPv2,SU11274,AAC,0.0259981902190984,0.458932823004973,662,pan-cancer mRNA,CTRPv2,VU0155056,AAC,-0.027796705884653,0.460654917092327,728,pan-cancer mRNA,CTRPv2,chlorambucil,AAC,0.0230489404221352,0.461841695654483,224,pan-cancer mRNA,CTRPv2,Nutlin-3,AAC,0.0250421269974515,0.466580797654283,507,pan-cancer mRNA,CTRPv2,pac-1,AAC,0.0258366714146092,0.468683310284859,525,pan-cancer mRNA,CTRPv2,BRD9876:MK-1775 (4:1 mol/mol),AAC,-0.0827388642534908,0.472007864552932,185,pan-cancer mRNA,CTRPv2,PF-4800567 hydrochloride,AAC,-0.0394441638408946,0.472418924223104,548,pan-cancer mRNA,CTRPv2,etomoxir,AAC,0.0269966123993281,0.472742639006761,289,pan-cancer mRNA,CTRPv2,SRT-1720,AAC,0.0269490509026969,0.472752146808752,657,pan-cancer mRNA,CTRPv2,barasertib,AAC,0.0229680831055779,0.473172113681257,63,pan-cancer mRNA,CTRPv2,Erlotinib,AAC,0.0247416829516645,0.475595640690868,287,pan-cancer mRNA,CTRPv2,SMER-3,AAC,0.0271916395062934,0.47757710202543,646,pan-cancer mRNA,CTRPv2,TAE684,AAC,0.0248356264127006,0.478752313153107,669,pan-cancer mRNA,CTRPv2,C6-ceramide,AAC,-0.0262062503398181,0.479270705738109,192,pan-cancer mRNA,CTRPv2,BI-2536,AAC,0.0220009472224151,0.482109138758982,74,pan-cancer mRNA,CTRPv2,BRD-K03911514,AAC,0.0371035098601751,0.495443877407399,105,pan-cancer mRNA,CTRPv2,STF-31,AAC,0.0237215646726613,0.496229098064851,660,pan-cancer mRNA,CTRPv2,AZ-3146,AAC,0.02385541432412,0.497453102805204,48,pan-cancer mRNA,CTRPv2,SR8278,AAC,0.0927715813781726,0.497473406428603,656,pan-cancer mRNA,CTRPv2,BRD6340,AAC,-0.0232167114885595,0.499826328021461,180,pan-cancer mRNA,CTRPv2,PD318088,AAC,-0.0234033004955069,0.499917081751523,538,pan-cancer mRNA,CTRPv2,BRD-K33514849,AAC,-0.0879983843400736,0.501521652760857,131,pan-cancer mRNA,CTRPv2,KH-CB19,AAC,-0.0307396567068475,0.501598178306865,394,pan-cancer mRNA,CTRPv2,Dasatinib,AAC,0.0241809826403543,0.502984358127315,262,pan-cancer mRNA,CTRPv2,Merck60,AAC,-0.0198559121227115,0.507935694599062,437,pan-cancer mRNA,CTRPv2,OSI-930,AAC,-0.0245824960107491,0.508045119163843,520,pan-cancer mRNA,CTRPv2,AT7867,AAC,0.0229938840433482,0.509670460268227,41,pan-cancer mRNA,CTRPv2,ceranib-2,AAC,0.0215078194720331,0.509867375970905,212,pan-cancer mRNA,CTRPv2,oligomycin a,AAC,-0.0233204624645635,0.511593436936247,515,pan-cancer mRNA,CTRPv2,pifithrin-alpha,AAC,-0.0243313877926255,0.511651174833285,559,pan-cancer mRNA,CTRPv2,BMS-536924,AAC,0.0233186723243582,0.513002585840483,89,pan-cancer mRNA,CTRPv2,SJ-172550,AAC,0.0248672417814105,0.51477656523301,642,pan-cancer mRNA,CTRPv2,SCH-529074,AAC,0.0246711801341611,0.51933141816337,616,pan-cancer mRNA,CTRPv2,Zebularine,AAC,0.0216227267085117,0.523309129780051,755,pan-cancer mRNA,CTRPv2,BRD-K99006945,AAC,0.0335741726635274,0.525535123322202,174,pan-cancer mRNA,UHNBreast,AZD6244,AAC,-0.193590968386529,0.526269315033209,56,pan-cancer mRNA,CTRPv2,ABT-263,AAC,-0.0221670786381688,0.529569207104963,16,pan-cancer mRNA,CTRPv2,neopeltolide,AAC,-0.0444783947171007,0.532247565168828,487,pan-cancer mRNA,CTRPv2,A-804598,AAC,-0.0282194183484321,0.535203032759585,12,pan-cancer mRNA,CTRPv2,foretinib,AAC,-0.0216667071376654,0.535896759524242,301,pan-cancer mRNA,CTRPv2,SB-225002,AAC,-0.0189227955831186,0.537062296881399,609,pan-cancer mRNA,CTRPv2,GW843682X,AAC,0.0214714937534145,0.537441984468328,345,pan-cancer mRNA,CTRPv2,NVP-BEZ235,AAC,0.0255311532300826,0.539619641250289,511,pan-cancer mRNA,CTRPv2,AZD0530,AAC,-0.0222479204866209,0.539840555543786,53,pan-cancer mRNA,CTRPv2,BRD-K27224038,AAC,-0.0565895235385321,0.541604928926757,123,pan-cancer mRNA,CTRPv2,salermide:PLX-4032 (12:1 mol/mol),AAC,-0.022750995653833,0.542417096529682,605,pan-cancer mRNA,CTRPv2,bendamustine,AAC,0.0229130030478018,0.544202460411465,70,pan-cancer mRNA,CTRPv2,BRD-K51831558,AAC,-0.032142162270003,0.5442650384103,147,pan-cancer mRNA,CTRPv2,navitoclax:piperlongumine (1:1 mol/mol),AAC,0.0213213958617791,0.546606776562714,478,pan-cancer mRNA,CTRPv2,BRD-K58730230,AAC,0.0449652646305865,0.547149705082,151,pan-cancer mRNA,CTRPv2,PLX4720,AAC,-0.0208319264221915,0.547391715453074,569,pan-cancer mRNA,CTRPv2,navitoclax:birinapant (1:1 mol/mol),AAC,-0.0214093016162342,0.551949966109738,475,pan-cancer mRNA,CTRPv2,BRD-A86708339,AAC,-0.0299062171948125,0.554402983151101,99,pan-cancer mRNA,CTRPv2,marinopyrrole A,AAC,0.0255554047320896,0.558659924824253,433,pan-cancer mRNA,CTRPv2,AZD6482,AAC,-0.0211544349185667,0.561951357654605,57,pan-cancer mRNA,CTRPv2,BRD-K28456706,AAC,-0.0208413083319897,0.564184799327026,125,pan-cancer mRNA,CTRPv2,Gefitinib,AAC,-0.0205890698767186,0.574627950365339,314,pan-cancer mRNA,CTRPv2,salermide,AAC,-0.0254191465221739,0.576346984773542,604,pan-cancer mRNA,CTRPv2,CHM-1,AAC,0.0179584595097053,0.577487298196941,225,pan-cancer mRNA,CTRPv2,Nilotinib,AAC,0.0200668587280787,0.582737274861564,491,pan-cancer mRNA,CTRPv2,VX-680,AAC,0.0617390725031242,0.583313143841109,730,pan-cancer mRNA,CTRPv2,BRD-K37390332,AAC,0.0210582410360892,0.58683335722166,136,pan-cancer mRNA,CTRPv2,tanespimycin:bortezomib (250:1 mol/mol),AAC,-0.0200246161961766,0.594382367138499,675,pan-cancer mRNA,CTRPv2,GDC-0941,AAC,-0.0192634239051164,0.594578387270637,313,pan-cancer mRNA,CTRPv2,BRD-K34099515,AAC,-0.0414751407019929,0.596059317256034,132,pan-cancer mRNA,CTRPv2,dabrafenib,AAC,0.0250484484673906,0.597995883318415,259,pan-cancer mRNA,CTRPv2,cediranib,AAC,0.028389277808306,0.598305230735429,210,pan-cancer mRNA,CTRPv2,triptolide,AAC,0.0183436629440902,0.599923990749761,706,pan-cancer mRNA,CTRPv2,AT-406,AAC,0.0245930387396171,0.605091684616542,38,pan-cancer mRNA,CTRPv2,BMS-345541,AAC,0.0183749872802316,0.608124252879142,87,pan-cancer mRNA,CTRPv2,UNC0638:navitoclax (1:1 mol/mol),AAC,0.0187455191065503,0.609315192586812,712,pan-cancer mRNA,CTRPv2,regorafenib,AAC,0.0192049372905669,0.611658717179605,593,pan-cancer mRNA,CTRPv2,BCL-LZH-4,AAC,0.027242140246467,0.613428381434014,67,pan-cancer mRNA,CTRPv2,silmitasertib,AAC,0.0197704600352741,0.613454581036846,638,pan-cancer mRNA,CTRPv2,MLN2480,AAC,0.0270743406636928,0.616236776237683,463,pan-cancer mRNA,CTRPv2,BRD-A02303741:carboplatin (1:1 mol/mol),AAC,0.0186664711916818,0.61729163481083,95,pan-cancer mRNA,CTRPv2,ETP-46464,AAC,0.0209392758520338,0.619731827847336,291,pan-cancer mRNA,CTRPv2,3-Cl-AHPC,AAC,0.0167452030727888,0.620144500077222,5,pan-cancer mRNA,CTRPv2,RAF265,AAC,-0.0202448065116358,0.622143603307763,590,pan-cancer mRNA,CTRPv2,SZ4TA2,AAC,0.0268782477216261,0.622849056199266,665,pan-cancer mRNA,CTRPv2,WP1130,AAC,-0.0171512169849701,0.625548673612559,734,pan-cancer mRNA,CTRPv2,nintedanib,AAC,0.0180174609360339,0.626602117655681,492,pan-cancer mRNA,CTRPv2,procarbazine,AAC,0.0189049185376914,0.628005099342798,573,pan-cancer mRNA,CTRPv2,tacrolimus,AAC,-0.0169223728464245,0.629032598209357,668,pan-cancer mRNA,CTRPv2,BRD-M00053801,AAC,-0.0226985558562177,0.63093148890069,176,pan-cancer mRNA,CTRPv2,pifithrin-mu,AAC,-0.0166022157296393,0.631318582828355,560,pan-cancer mRNA,CTRPv2,PF-573228,AAC,0.0161483237997247,0.633662151389217,551,pan-cancer mRNA,CTRPv2,CIL55,AAC,-0.0288408140170762,0.634890222921387,232,pan-cancer mRNA,CTRPv2,KW-2449,AAC,-0.0141152769216011,0.63707272150815,411,pan-cancer mRNA,CTRPv2,R428,AAC,-0.0200093760713512,0.637576344654873,589,pan-cancer mRNA,CTRPv2,AZD4547,AAC,-0.018061356978519,0.639716414717317,55,pan-cancer mRNA,CTRPv2,UNC0638,AAC,0.0168112943916359,0.64176364439907,711,pan-cancer mRNA,CTRPv2,Bortezomib,AAC,-0.0161662325702571,0.642918286349496,92,pan-cancer mRNA,CTRPv2,TPCA-1,AAC,-0.0148675319200088,0.645511643026114,699,pan-cancer mRNA,CTRPv2,KU-0063794,AAC,-0.0158554530634707,0.654664102784288,408,pan-cancer mRNA,CTRPv2,NVP-BSK805,AAC,0.0150650447561195,0.655864176871836,512,pan-cancer mRNA,CTRPv2,FK866,AAC,0.0168807975741945,0.655992093405726,298,pan-cancer mRNA,CTRPv2,tubastatin A,AAC,0.0234412031912812,0.657219769859598,707,pan-cancer mRNA,CTRPv2,Vandetanib,AAC,-0.0158313461080485,0.660936568854432,717,pan-cancer mRNA,CTRPv2,CBB-1007,AAC,0.0238312477507704,0.663393101044872,204,pan-cancer mRNA,CTRPv2,GMX-1778,AAC,0.0152902580482549,0.664056261274394,319,pan-cancer mRNA,UHNBreast,lapatinib,AAC,0.133049593480932,0.664785262688872,415,pan-cancer mRNA,CTRPv2,IPR-456,AAC,-0.0163084798547499,0.665872787274001,366,pan-cancer mRNA,CTRPv2,NSC95397,AAC,-0.0141284668343593,0.666797405880518,504,pan-cancer mRNA,CTRPv2,phloretin,AAC,0.0146025380103222,0.668070306024309,557,pan-cancer mRNA,CTRPv2,BRD-K11533227,AAC,0.015980013650304,0.668745919364003,110,pan-cancer mRNA,CTRPv2,lomeguatrib,AAC,-0.0156827126556229,0.671332785455255,426,pan-cancer mRNA,CTRPv2,SR1001,AAC,-0.0160610635767329,0.672656122678755,655,pan-cancer mRNA,CTRPv2,Vorinostat,AAC,-0.0137245402250752,0.675289642831202,725,pan-cancer mRNA,CTRPv2,IU1,AAC,0.0161406227535711,0.675374526898743,377,pan-cancer mRNA,CTRPv2,ISOX,AAC,0.013224146568191,0.676072506745799,371,pan-cancer mRNA,CTRPv2,BRD-K52037352,AAC,0.0168375833698564,0.678677085774014,148,pan-cancer mRNA,CTRPv2,leptomycin B,AAC,0.0137536324859735,0.680874322220052,421,pan-cancer mRNA,CTRPv2,ibrutinib,AAC,0.0165650358853831,0.689167610759551,356,pan-cancer mRNA,CTRPv2,trifluoperazine,AAC,-0.015698173881271,0.690063098876247,705,pan-cancer mRNA,CTRPv2,decitabine,AAC,0.0109102730200827,0.690668626228384,264,pan-cancer mRNA,CTRPv2,decitabine:navitoclax (2:1 mol/mol),AAC,0.0123180859193822,0.691606271115399,266,pan-cancer mRNA,CTRPv2,betulinic acid,AAC,-0.014872562242028,0.698467941733194,71,pan-cancer mRNA,CTRPv2,BRD-K19103580,AAC,-0.0142664922538813,0.701112068113588,117,pan-cancer mRNA,CTRPv2,navitoclax:MST-312 (1:1 mol/mol),AAC,-0.0138687007303694,0.701306852481651,477,pan-cancer mRNA,CTRPv2,Fumonisin B1,AAC,0.0138045601722308,0.707613337082037,309,pan-cancer mRNA,CTRPv2,BRD-K48477130,AAC,0.0209662094494849,0.70936285141894,143,pan-cancer mRNA,CTRPv2,selumetinib:navitoclax (8:1 mol/mol),AAC,0.0135967209937649,0.71051101533993,623,pan-cancer mRNA,CTRPv2,SID 26681509,AAC,0.0141816801217635,0.711267927717847,635,pan-cancer mRNA,CTRPv2,LY-2183240,AAC,0.0116499445993816,0.711383688102254,430,pan-cancer mRNA,CTRPv2,hyperforin,AAC,-0.0142892406373051,0.711844583657022,352,pan-cancer mRNA,CTRPv2,SNX-2112:bortezomib (250:1 mol/mol),AAC,0.0119259172907571,0.715527937390265,650,pan-cancer mRNA,CTRPv2,XL765,AAC,0.0135525313027872,0.716328559655263,741,pan-cancer mRNA,CTRPv2,SB-431542,AAC,-0.0136404013508188,0.72017640036221,611,pan-cancer mRNA,CTRPv2,BRD1812,AAC,-0.0126245269127202,0.720648583578597,177,pan-cancer mRNA,CTRPv2,BRD-K01737880,AAC,-0.0447268580914809,0.721867085987923,101,pan-cancer mRNA,CTRPv2,ouabain,AAC,0.0123058373525992,0.72328871529242,522,pan-cancer mRNA,CTRPv2,BRD-K09587429,AAC,-0.0140917385655383,0.723305891475774,109,pan-cancer mRNA,CTRPv2,SB-743921,AAC,0.0114453314855354,0.724821472605083,613,pan-cancer mRNA,CTRPv2,KU-55933,AAC,-0.0126470592872328,0.726961151867231,409,pan-cancer mRNA,CTRPv2,Mdivi-1,AAC,0.0125594871955121,0.730710481410629,435,pan-cancer mRNA,CTRPv2,CIL70,AAC,0.0162699790144779,0.731447557225142,235,pan-cancer mRNA,CTRPv2,BRD-K17060750,AAC,0.0128160265044349,0.732331859951782,116,pan-cancer mRNA,CTRPv2,CD-1530,AAC,0.0131517041298153,0.732761003964572,208,pan-cancer mRNA,CTRPv2,SGX-523,AAC,0.0125260859075316,0.735257130530286,633,pan-cancer mRNA,CTRPv2,WAY-362450,AAC,-0.0125428409095108,0.736335600064383,732,pan-cancer mRNA,CTRPv2,MS-275,AAC,-0.0108457558397031,0.737582902276055,468,pan-cancer mRNA,CTRPv2,AZD-7545,AAC,0.0122355757133935,0.738279073481834,52,pan-cancer mRNA,CTRPv2,GSK1120212,AAC,-0.0163830588908543,0.738358937642381,329,pan-cancer mRNA,CTRPv2,azacitidine,AAC,0.0124484105579174,0.738816478229866,50,pan-cancer mRNA,CTRPv2,vorinostat:navitoclax (4:1 mol/mol),AAC,-0.0116960355088632,0.73999643228364,727,pan-cancer mRNA,CTRPv2,decitabine:carboplatin (1:1 mol/mol),AAC,0.00909568521418404,0.746462009675075,265,pan-cancer mRNA,CTRPv2,Curcumin,AAC,-0.0109893347533639,0.74683746153446,252,pan-cancer mRNA,CTRPv2,prochlorperazine,AAC,-0.0116936914361231,0.748519212432095,574,pan-cancer mRNA,CTRPv2,skepinone-L,AAC,0.0160408995256271,0.756200424051445,643,pan-cancer mRNA,CTRPv2,LY-2157299,AAC,-0.0524473079534775,0.760576176546316,429,pan-cancer mRNA,CTRPv2,ABT-888,AAC,-0.0107274702943991,0.768967720520752,18,pan-cancer mRNA,CTRPv2,clofarabine,AAC,-0.00846091869222671,0.770140755009603,238,pan-cancer mRNA,CTRPv2,BRD-K75293299,AAC,-0.0484360252051299,0.770449987097652,160,pan-cancer mRNA,CTRPv2,BRD-K86535717,AAC,-0.048796267948434,0.770554902967012,166,pan-cancer mRNA,CTRPv2,BMS-754807,AAC,0.0099797402483815,0.772041935740271,91,pan-cancer mRNA,CTRPv2,SNX-2112,AAC,0.00901202486929212,0.774814889106097,649,pan-cancer mRNA,CTRPv2,StemRegenin 1,AAC,-0.00990728179401395,0.774846009589996,659,pan-cancer mRNA,CTRPv2,PIK-93,AAC,0.0100052536025287,0.775135186417171,561,pan-cancer mRNA,CTRPv2,PL-DI,AAC,0.0088681137633259,0.775365705295853,565,pan-cancer mRNA,CTRPv2,BEC,AAC,0.0476658269634087,0.775465054774751,68,pan-cancer mRNA,UHNBreast,Erlotinib,AAC,0.0832036779783052,0.777342341358035,287,pan-cancer mRNA,CTRPv2,erismodegib,AAC,-0.0104719980144593,0.779381329760904,285,pan-cancer mRNA,CTRPv2,simvastatin,AAC,0.0109231851762036,0.779542647295292,639,pan-cancer mRNA,CTRPv2,PF-184,AAC,0.00914003062199379,0.783541710072053,542,pan-cancer mRNA,CTRPv2,SB-525334,AAC,0.0100992291111451,0.783695794668378,612,pan-cancer mRNA,CTRPv2,CI-976,AAC,-0.0107466055520967,0.784373492562196,227,pan-cancer mRNA,CTRPv2,niclosamide,AAC,-0.00963034294345607,0.787994341126463,490,pan-cancer mRNA,CTRPv2,BRD-K34222889,AAC,0.00822302342240633,0.790723226996079,133,pan-cancer mRNA,CTRPv2,BRD-K26531177,AAC,0.00967714020755224,0.793379861513123,120,pan-cancer mRNA,CTRPv2,sotrastaurin,AAC,-0.0101772959316263,0.795420275665306,652,pan-cancer mRNA,CTRPv2,epigallocatechin-3-monogallate,AAC,-0.00922049571010767,0.797172024026288,281,pan-cancer mRNA,CTRPv2,semagacestat,AAC,-0.00943025834542869,0.798457120729579,629,pan-cancer mRNA,CTRPv2,ATRA,AAC,-0.00880407766311966,0.798681014741912,42,pan-cancer mRNA,CTRPv2,BRD-K79669418,AAC,-0.0133647843461511,0.798957741068109,162,pan-cancer mRNA,CTRPv2,BRD-K42260513,AAC,-0.014242467932747,0.799829178939938,139,pan-cancer mRNA,CTRPv2,CHEMBL374350,AAC,0.00954516662188305,0.799970070752677,222,pan-cancer mRNA,CTRPv2,Sunitinib,AAC,0.0087436187401809,0.800573154180413,663,pan-cancer mRNA,CTRPv2,spautin-1,AAC,-0.00933399978221535,0.801809980463161,653,pan-cancer mRNA,CTRPv2,BRD-K71781559,AAC,-0.00957667060397374,0.804044038272161,158,pan-cancer mRNA,UHNBreast,paclitaxel,AAC,0.0801048263744968,0.804543930923163,526,pan-cancer mRNA,CTRPv2,B02,AAC,-0.00879669324529207,0.807484944251945,60,pan-cancer mRNA,CTRPv2,ML334 diastereomer,AAC,0.0107746468047284,0.807990233398916,461,pan-cancer mRNA,CTRPv2,MST-312,AAC,-0.00847012275091709,0.808155487612618,469,pan-cancer mRNA,CTRPv2,MK-2206,AAC,-0.00876937293178048,0.808403029992846,448,pan-cancer mRNA,CTRPv2,GSK-J4,AAC,-0.0256219974705813,0.811545010194134,325,pan-cancer mRNA,CTRPv2,CIL41,AAC,0.0127963764390977,0.811630455306965,231,pan-cancer mRNA,CTRPv2,Compound 1541A,AAC,0.00932359709386319,0.812648308137675,241,pan-cancer mRNA,CTRPv2,ciclopirox,AAC,-0.00769902071664263,0.812827665806005,228,pan-cancer mRNA,CTRPv2,KHS101,AAC,-0.00869106061685249,0.814409793079333,395,pan-cancer mRNA,CTRPv2,alvocidib,AAC,0.0115430914735429,0.814549046220482,29,pan-cancer mRNA,CTRPv2,BRD-K20514654,AAC,-0.0119783793909413,0.81686850979724,118,pan-cancer mRNA,CTRPv2,Docetaxel,AAC,0.0113129524576837,0.817469613505212,271,pan-cancer mRNA,CTRPv2,ABT-199,AAC,-0.0097128014872141,0.820786698725338,15,pan-cancer mRNA,CTRPv2,RITA,AAC,0.00795952101905468,0.821659654482248,597,pan-cancer mRNA,CTRPv2,TG-100-115,AAC,0.00825006435747209,0.822653789113201,682,pan-cancer mRNA,CTRPv2,Imatinib,AAC,0.00809875298436467,0.82374735785678,361,pan-cancer mRNA,CTRPv2,BRD-A94377914,AAC,-0.0102672654595549,0.824621169735839,100,pan-cancer mRNA,CTRPv2,selumetinib:GDC-0941 (4:1 mol/mol),AAC,-0.00778243597588086,0.827055254251826,620,pan-cancer mRNA,CTRPv2,JW-480,AAC,-0.00768346242080936,0.83863178387677,389,pan-cancer mRNA,CTRPv2,cabozantinib,AAC,0.00732846299402812,0.840272764304982,193,pan-cancer mRNA,CTRPv2,JW-74,AAC,0.00909897570015735,0.840950065741595,393,pan-cancer mRNA,CTRPv2,Tamoxifen,AAC,-0.00739390944920871,0.843645637291403,673,pan-cancer mRNA,CTRPv2,Bax channel blocker,AAC,-0.0072314635876088,0.848409161662841,65,pan-cancer mRNA,CTRPv2,canertinib,AAC,0.00691568052319487,0.850029900949698,196,pan-cancer mRNA,CTRPv2,BRD-K64610608,AAC,-0.00722197442294928,0.850913185411162,154,pan-cancer mRNA,CTRPv2,GDC-0879,AAC,0.00656979410265346,0.852308573091151,312,pan-cancer mRNA,CTRPv2,UNC0321,AAC,-0.00660555866569826,0.858036537378784,710,pan-cancer mRNA,CTRPv2,CD-437,AAC,0.00572397100812461,0.858240013020288,209,pan-cancer mRNA,CTRPv2,TGX221,AAC,0.00644840428190231,0.861984763421275,684,pan-cancer mRNA,CTRPv2,JW-55,AAC,-0.013030740217514,0.865568169065275,390,pan-cancer mRNA,CTRPv2,AC55649,AAC,0.00638839403342444,0.865960399364898,20,pan-cancer mRNA,CTRPv2,OSI-027,AAC,0.00588707291224619,0.866148841314402,518,pan-cancer mRNA,CTRPv2,navitoclax:sorafenib (1:1 mol/mol),AAC,0.00583585809533415,0.866568976751754,481,pan-cancer mRNA,CTRPv2,KPT185,AAC,-0.00568368576459822,0.880631242727743,406,pan-cancer mRNA,CTRPv2,importazole,AAC,0.00566863467747009,0.882266069423262,362,pan-cancer mRNA,CTRPv2,GSK2636771,AAC,-0.00605091857546932,0.887444122432564,334,pan-cancer mRNA,CTRPv2,sirolimus:bortezomib (250:1 mol/mol),AAC,-0.00472014582455307,0.88798336004909,640,pan-cancer mRNA,CTRPv2,BIRB 0796,AAC,0.00501783279686006,0.894744270121628,79,pan-cancer mRNA,CTRPv2,ABT-737,AAC,-0.00479605407054222,0.895091402324191,17,pan-cancer mRNA,CTRPv2,HBX-41108,AAC,-0.00544973148314916,0.8958019868955,346,pan-cancer mRNA,CTRPv2,PD 153035,AAC,-0.00520801474412484,0.899886607962557,534,pan-cancer mRNA,CTRPv2,carboplatin:etoposide (40:17 mol/mol),AAC,-0.00357581427884015,0.903310881621007,198,pan-cancer mRNA,CTRPv2,BRD-A05715709,AAC,-0.00671531613718205,0.905128160469053,97,pan-cancer mRNA,CTRPv2,navitoclax:PLX-4032 (1:1 mol/mol),AAC,0.00414278645762245,0.905528650729019,480,pan-cancer mRNA,CTRPv2,quizartinib,AAC,0.00441451865657647,0.90588419346497,587,pan-cancer mRNA,CTRPv2,KU 0060648,AAC,-0.0041706417413963,0.906538147302479,407,pan-cancer mRNA,CTRPv2,WZ4002,AAC,-0.00507498883994771,0.90700342104879,737,pan-cancer mRNA,CTRPv2,BRD-A71883111,AAC,0.00385633049782912,0.916115233617186,98,pan-cancer mRNA,CTRPv2,ML312,AAC,0.00802971470262523,0.91626457082935,459,pan-cancer mRNA,CTRPv2,necrosulfonamide,AAC,0.00396079029868817,0.917271965036665,484,pan-cancer mRNA,CTRPv2,navitoclax:pluripotin (1:1 mol/mol),AAC,0.00367995688220584,0.918213232461116,479,pan-cancer mRNA,CTRPv2,CAY10576,AAC,-0.00396333323527622,0.920186251799848,200,pan-cancer mRNA,CTRPv2,triazolothiadiazine,AAC,0.00294630537385052,0.92051201615229,702,pan-cancer mRNA,CTRPv2,FGIN-1-27,AAC,-0.0166516783000355,0.922812945488172,295,pan-cancer mRNA,CTRPv2,MI-2,AAC,0.00504008496562797,0.924747418314579,443,pan-cancer mRNA,CTRPv2,isonicotinohydroxamic acid,AAC,-0.00416876096228995,0.927902482914599,370,pan-cancer mRNA,CTRPv2,MLN2238,AAC,0.00304962626672251,0.92877422857117,462,pan-cancer mRNA,CTRPv2,selumetinib:decitabine (4:1 mol/mol),AAC,0.00301756089227292,0.928894929950209,619,pan-cancer mRNA,CTRPv2,Obatoclax Mesylate,AAC,-0.00277294677932652,0.934480333055121,514,pan-cancer mRNA,CTRPv2,myricetin,AAC,0.00284302248501495,0.940285745904905,470,pan-cancer mRNA,CTRPv2,methylstat,AAC,0.00264215346973631,0.948751806274139,439,pan-cancer mRNA,CTRPv2,BRD-K13999467,AAC,0.00228252042937831,0.94948934840512,112,pan-cancer mRNA,CTRPv2,AZD7762,AAC,0.00203705654244836,0.95022207926584,58,pan-cancer mRNA,CTRPv2,16-beta-bromoandrosterone,AAC,-0.00230132879683721,0.950520212494495,2,pan-cancer mRNA,CTRPv2,BRD-K34485477,AAC,-0.00468436083335043,0.951638951671689,134,pan-cancer mRNA,CTRPv2,NPC-26,AAC,0.00216786457624402,0.955666394238694,493,pan-cancer mRNA,CTRPv2,BRD-K97651142,AAC,0.00208191301586626,0.955905735677437,173,pan-cancer mRNA,CTRPv2,brivanib,AAC,0.00183039718414025,0.959035742737567,187,pan-cancer mRNA,CTRPv2,momelotinib,AAC,-0.00173398227766919,0.959762705344986,465,pan-cancer mRNA,CTRPv2,BRD8899,AAC,0.00186108457772667,0.960552761760303,181,pan-cancer mRNA,CTRPv2,bafilomycin A1,AAC,0.00700348937772686,0.960728334412431,61,pan-cancer mRNA,CTRPv2,blebbistatin,AAC,0.00358676360459682,0.962428819992684,83,pan-cancer mRNA,CTRPv2,avrainvillamide,AAC,-0.00173190695251881,0.966071825437119,46,pan-cancer mRNA,CTRPv2,FQI-1,AAC,-0.00186191030470318,0.968079428410115,302,pan-cancer mRNA,CTRPv2,CIL55A,AAC,0.00197208112771694,0.968623020314408,233,pan-cancer mRNA,CTRPv2,BRD-K96970199,AAC,0.00362030613463875,0.968962513946373,172,pan-cancer mRNA,CTRPv2,MI-1,AAC,0.00137243923483837,0.972122250634514,442,pan-cancer mRNA,CTRPv2,BMS-270394,AAC,-0.00120993981950317,0.973608611166839,86,pan-cancer mRNA,CTRPv2,PF-3758309,AAC,0.00088855842748061,0.983750823118498,544,pan-cancer mRNA,CTRPv2,968,AAC,0.00141346863381851,0.983824423447674,9,pan-cancer mRNA,CTRPv2,SNS-032,AAC,0.000724444821663726,0.983887941488049,648,pan-cancer mRNA,CTRPv2,BYL-719,AAC,-0.000839891922481684,0.984313382967055,191,pan-cancer mRNA,CTRPv2,nelarabine,AAC,-0.000667424037270651,0.986122892139329,485,pan-cancer mRNA,CTRPv2,dinaciclib,AAC,0.000799310928256253,0.986832715665472,268,pan-cancer mRNA,CTRPv2,BRD-K96431673,AAC,0.00237234263541054,0.988580184787876,171,pan-cancer mRNA,CTRPv2,Ki8751,AAC,0.000302495599308392,0.993258860920954,396,pan-cancer mRNA,CTRPv2,CCT036477,AAC,0.000149670255892449,0.996385463704641,207,pan-cancer